HMS Holdings Corp (HMSY) News
Filter HMSY News Items
HMSY News Results
|Event/Time||Symbol||Company||News Detail||Start||End||Change||POWR Rating|
|Loading, please wait...|
Latest HMSY News From Around the Web
Below are the latest news stories about Hms Holdings Corp that investors may wish to consider to help them evaluate HMSY as an investment opportunity.
Q1 2020 HMS Holdings Corp Earnings Call
This development, which is in response to the challenges brought on by the pandemic, is expected to boost Varian's (VAR) Oncology segment.
Baxter (BAX) receives the CE marking and regulatory approval for the Evo IQ Syringe Infusion system that will help in optimizing efficiency for clinicians.
Investor confidence is high in Surmodics (SRDX) stock, thanks to solid prospects.
After looking at HMS Holdings Corp.'s (NasdaqGS:HMSY) latest earnings announcement (31 March 2020), I found it useful...
OPKO Health's (OPK) subsidiary, BioReference Laboratories collaborates with MagnaCare to offer antibody testing to Labor groups in New York metropolitan area.
HMSY vs. TRHC: Which Stock Is the Better Value Option?
Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, stiff competition remains a concern.
Nevro (NVRO) received CE mark approval for the Senza Omnia SCS system, which is likely to boost its international presence.
ResMed (RMD) global sales increase on ramped-up demand for its critical care support products.